Markets:

Overview

News

Currencies

International

Treasuries

Terumo Corp ADR (OP:TRUMY)

13.44 -0.39 (-2.82%)

Streaming Delayed Price Updated: 3:33 PM EST, Jan 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Terumo Corp ADR

The Thrombectomy Titan: Boston Scientific Shakes MedTech with $14.5 Billion Penumbra Acquisition

January 15, 2026

MARLBOROUGH, MA – In a move that has sent shockwaves through the medical device sector, Boston Scientific Corporation (NYSE:BSX) announced today, January 15, 2026, a definitive agreement to acquire...

Via MarketMinute

Topics Artificial Intelligence

Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst ↗

January 23, 2024

Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.

Via Benzinga

Why Shares of Orchestra BioMed Jumped Tuesday ↗

September 19, 2023

The company got approval from the FDA to go ahead with a pivotal study for a hypertension therapy.

Via The Motley Fool

Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?

March 01, 2023

By David Willey, Benzinga

Via TheNewswire.com

Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?

March 01, 2023

Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?

Via News Direct

Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? ↗

March 01, 2023

The medical device and supply manufacturing industry is focused on the design and production of medical instruments and devices.

Via Benzinga

With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO ↗

February 15, 2023

Medical device company Sharps Technology Inc. (NASDAQ: STSS) is taking stock as it approaches one year since its initial public offering (IPO). Since its IPO, the company has taken major strides in...

Via Benzinga

Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products

January 17, 2023

By David Willey, Benzinga

Via TheNewswire.com

Topics Economy

Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products

January 17, 2023

Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products

Via News Direct

Topics Economy

Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products ↗

January 17, 2023

Sharps Technology, Inc. (NASDAQ: STSS) recently announced that the Company will be commercializing cutting-edge prefillable syringe system products to provide new solutions to customers in the...

Via Benzinga

Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry ↗

January 09, 2023

Medical device company Sharps Technology, Inc. (NASDAQ: STSS) is closing out a successful year after its April initial public offering (IPO) on the NASDAQ market. The company focuses on the development...

Via Benzinga

Inspira Technologies, The Company That Aims To Change 50 Years Of Therapeutic Paradigm In Patients With Respiratory Failure ↗

March 07, 2022

Photo by Mockup Graphics on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice....

Via Benzinga

Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029

January 12, 2023

EQNX::TICKER_START (NASDAQ:STSS),(NYSE:BDX),(NYSE:CAH),(NYSE:NVO),(OTCPK:TRUMY),(NASDAQ:STSSW) EQNX::TICKER_END

Via FinancialNewsMedia

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.